Home/Publication/Sherpa, Qiming Back Targeted Cancer Therapies
Sherpa, Qiming Back Targeted Cancer Therapies 

14 Oct 2026

US$ 20.00

Sherpa Healthcare Partners has led the over Rmb300 m (US$44.8 m) series A funding round of Allygen Biologics ......

Price / article: US$20.00
OR existing subscriber
Related Publications

Singularity AMC has led a US$10 m funding round in MakeO Healthcare Technologies Pvt Ltd (MakeO), a clinical beauty and...

Impact Fund Denmark (IFD) has invested US$35 m in GreenCell Mobility Pvt Ltd (GreenCell), an electric...

Connect With Us

We love to share Asia PE insights and news from time to time. Drop us your email address if you like to hear from us.

Rest assured that your email address will not be shared, as we hate spams as much as you do.